The Efficacy and Safety of Initial Triple Versus Initial Dual Oral Combination Therapy in Patients With Newly Diagnosed Pulmonary Arterial Hypertension: A Multi-center, Double-blind, Placebo-controlled, Phase 3b Study
收藏DataCite Commons2025-10-28 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00011893/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The objective of this clinical trial is to compare the efficacy and safety of an initial triple oral treatment regimen (macitentan, tadalafil, selexipag) versus an initial dual oral treatment regimen (macitentan, tadalafil, placebo) in newly diagnosed, treatment-naïve patients with pulmonary arterial hypertension.
提供机构：
Vivli
创建时间：
2025-10-27
